ArticleInternational journal of molecular sciences2022

Utility of a Molecular Signature for Predicting Recurrence and Progression in Non-Muscle-Invasive Bladder Cancer Patients: Comparison with the EORTC, CUETO and 2021 EAU Risk Groups.

Xuan-Mei Piao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.